ESMO Immuno-Oncology Congress 2019

11.-14. Dezember 2019
Genf, Schweiz

Teilnehmer: Dr. Andriy Krendyukov, VP Medical Affairs

Poster-Präsentation: "The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: rationale and results from an enhanced TiRP model"

19th Annual PepTalk

20.-24. Januar 2020
San Diego, CA, USA

Teilnehmer: Dr. Katharina Billian-Frey, Senior Scientist Drug Discovery/Protein Engineering

Präsentation am 20. Januar, 14:35 Uhr: HERA-CD40L: A Unique Hexavalent CD40 Agonist for Cancer Immunotherapy

AACR Annual Meeting 2020

24.-29. April 2020
San Diego, CA, USA

Teilnehmer:
Dr. Christian Gieffers, VP Protein Chemistry
Dr. Christian Merz, Head of Cellular Analytics
Dr. Meinolf Thiemann, Director Protein Analytics